Followers

December 16, 2023

US FDA approves Arcutis' drug to treat chronic skin disease

The health regulator's nod makes roflumilast foam the first topical drug for treating moderate to severe seborrheic dermatitis with a new mechanism of action in over two decades, according to the company.


No comments:

Post a Comment